Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 7, 2006Journal of Clinical InvestigationOpen Access

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMaría Borrell-PagésInstituto de Salud Carlos III

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

María Borrell-Pagés (2006) studied this question.

synapsesocial.com/papers/6a72be8f35aa2c282ce36924https://doi.org/10.1172/jci27607
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1THE GENETICS OF <i>CAENORHABDITIS ELEGANS</i>1974 · 15,621 citations
  2. 2Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease2001 · 1,337 citations
  3. 3Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate‐independent mechanisms2004 · 82 citations
  4. 4The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism1984 · 46 citations